BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28511221)

  • 1. [PSMA-Radioguided Surgery for Salvage Lymphadenectomy in Recurrent Prostate Cancer].
    Rauscher I; Eiber M; Maurer T
    Aktuelle Urol; 2017 Apr; 48(2):148-152. PubMed ID: 28511221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of
    Rauscher I; Düwel C; Wirtz M; Schottelius M; Wester HJ; Schwamborn K; Haller B; Schwaiger M; Gschwend JE; Eiber M; Maurer T
    BJU Int; 2017 Jul; 120(1):40-47. PubMed ID: 27862863
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Maurer T; Robu S; Schottelius M; Schwamborn K; Rauscher I; van den Berg NS; van Leeuwen FWB; Haller B; Horn T; Heck MM; Gschwend JE; Schwaiger M; Wester HJ; Eiber M
    Eur Urol; 2019 Apr; 75(4):659-666. PubMed ID: 29625755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel technology of molecular radio-guidance for lymph node dissection in recurrent prostate cancer by PSMA-ligands.
    Rauscher I; Horn T; Eiber M; Gschwend JE; Maurer T
    World J Urol; 2018 Apr; 36(4):603-608. PubMed ID: 29372353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastases-yield and Prostate-specific Antigen Kinetics Following Salvage Lymph Node Dissection for Prostate Cancer: A Comparison Between Conventional Surgical Approach and Prostate-specific Membrane Antigen-radioguided Surgery.
    Knipper S; Tilki D; Mansholt J; Berliner C; Bernreuther C; Steuber T; Maurer T; Graefen M
    Eur Urol Focus; 2019 Jan; 5(1):50-53. PubMed ID: 30292421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PSMA-radioguided surgery in localised recurrent prostate cancer].
    Horn T; Rauscher I; Eiber M; Gschwend JE; Maurer T
    Urologe A; 2017 Nov; 56(11):1417-1423. PubMed ID: 29022058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer.
    Maurer T; Weirich G; Schottelius M; Weineisen M; Frisch B; Okur A; Kübler H; Thalgott M; Navab N; Schwaiger M; Wester HJ; Gschwend JE; Eiber M
    Eur Urol; 2015 Sep; 68(3):530-4. PubMed ID: 25957851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided Surgery.
    Knipper S; Mehdi Irai M; Simon R; Koehler D; Rauscher I; Eiber M; van Leeuwen FWB; van Leeuwen P; de Barros H; van der Poel H; Budäus L; Steuber T; Graefen M; Tennstedt P; Heck MM; Horn T; Maurer T
    Eur Urol; 2023 Jan; 83(1):62-69. PubMed ID: 35718637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific membrane antigen-guided salvage lymph node dissection in recurrent prostate cancer: a novel technology to detect lymph node metastases.
    Maurer T; Gschwend JE; Eiber M
    Curr Opin Urol; 2018 Mar; 28(2):191-196. PubMed ID: 29028767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.
    Rauscher I; Maurer T; Beer AJ; Graner FP; Haller B; Weirich G; Doherty A; Gschwend JE; Schwaiger M; Eiber M
    J Nucl Med; 2016 Nov; 57(11):1713-1719. PubMed ID: 27261524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robot-assisted Prostate-specific Membrane Antigen-radioguided Salvage Surgery in Recurrent Prostate Cancer Using a DROP-IN Gamma Probe: The First Prospective Feasibility Study.
    de Barros HA; van Oosterom MN; Donswijk ML; Hendrikx JJMA; Vis AN; Maurer T; van Leeuwen FWB; van der Poel HG; van Leeuwen PJ
    Eur Urol; 2022 Jul; 82(1):97-105. PubMed ID: 35339318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support.
    Falkenbach F; Knipper S; Koehler D; Ambrosini F; Steuber T; Graefen M; Budäus L; Eiber M; Lunger L; Lischewski F; Heck MM; Maurer T
    World J Urol; 2023 Sep; 41(9):2343-2350. PubMed ID: 37515651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study.
    Gandaglia G; Mazzone E; Stabile A; Pellegrino A; Cucchiara V; Barletta F; Scuderi S; Robesti D; Leni R; Samanes Gajate AM; Picchio M; Gianolli L; Brembilla G; De Cobelli F; van Oosterom MN; van Leeuwen FWB; Montorsi F; Briganti A
    Eur Urol; 2022 Oct; 82(4):411-418. PubMed ID: 35879127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer.
    Horn T; Krönke M; Rauscher I; Haller B; Robu S; Wester HJ; Schottelius M; van Leeuwen FWB; van der Poel HG; Heck M; Gschwend JE; Weber W; Eiber M; Maurer T
    Eur Urol; 2019 Oct; 76(4):517-523. PubMed ID: 30987843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PSMA-radioguided surgery in localized recurrent prostate cancer : Current and future aspects].
    Rauscher I; Eiber M; Jilg CA; Gschwend JE; Maurer T
    Urologe A; 2017 Jan; 56(1):18-23. PubMed ID: 27885455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-Specific Membrane Antigen-Targeted Radioguided Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients with a Suspicion of Locoregional Lymph Node Metastases: The DETECT Trial.
    Schilham MGM; Somford DM; Küsters-Vandevelde HVN; Hermsen R; van Basten JPA; Hoekstra RJ; Scheenen TWJ; Gotthardt M; Sedelaar JPM; Rijpkema M
    J Nucl Med; 2024 Mar; 65(3):423-429. PubMed ID: 38176721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate Cancer.
    Gondoputro W; Scheltema MJ; Blazevski A; Doan P; Thompson JE; Amin A; Geboers B; Agrawal S; Siriwardana A; Van Leeuwen PJ; van Oosterom MN; Van Leeuwen FWB; Emmett L; Stricker PD
    J Nucl Med; 2022 Nov; 63(11):1659-1664. PubMed ID: 35241483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 67 Ga-PSMA I&T for Radioguided Surgery of Lymph Node Metastases in Patients With Biochemical Recurrence of Prostate Cancer.
    Winkens T; Berger FP; Foller S; Greiser J; Groeber S; Grimm MO; Freesmeyer M; Kuehnel C
    Clin Nucl Med; 2023 Jul; 48(7):600-607. PubMed ID: 37145416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of
    Koehler D; Sauer M; Klutmann S; Apostolova I; Lehnert W; Budäus L; Knipper S; Maurer T
    J Nucl Med; 2023 Jan; 64(1):59-62. PubMed ID: 35835582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapatient Comparison of 111In-PSMA I&T SPECT/CT and Hybrid 68Ga-HBED-CC PSMA PET in Patients With Early Recurrent Prostate Cancer.
    Rauscher I; Maurer T; Souvatzoglou M; Beer AJ; Vag T; Wirtz M; Weirich G; Wester HJ; Gschwend JE; Schwaiger M; Schottelius M; Eiber M
    Clin Nucl Med; 2016 Sep; 41(9):e397-402. PubMed ID: 27276206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.